S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Photronics Investors Face September Deadline for Securities Lawsuit

Investors who lost more than $100,000 in Photronics, Inc. stock between December 2025 and May 2026 have until September 4 to petition the court to act as lead plaintiff in a pending securities fraud class action. The litigation centers on allegations that the company misled shareholders regarding its product pipeline stability.

Photronics Investors Face September Deadline for Securities Lawsuit
Photo: Bio & News

The lawsuit, filed by the Rosen Law Firm, alleges that Photronics executives issued overly optimistic guidance while concealing significant operational failures. Specifically, the complaint points to a stalled seasonal recovery following the Chinese New Year and a critical bottleneck in the company's design release pipeline. These undisclosed issues allegedly rendered the firm's growth projections unattainable, leading to financial losses for shareholders when the reality of the situation surfaced.

Those who purchased PLAB securities during the specified class period are not currently represented by counsel unless they choose to retain an attorney or join the existing action. While investors have the option to remain absent class members, those seeking to serve as lead plaintiff must file their motion with the court by the September deadline. The Rosen Law Firm, which has previously secured substantial settlements in similar shareholder litigation, is managing the case on a contingency fee basis.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!